Skip to main content

Hannah Moscovitch has become one of English-Canada's most-produced playwrights only in the past decade.

Peter Power/The Globe and Mail

Two English-language and two French-language playwrights are up for this year's $100,000 Siminovitch Prize - but the contest for the richest prize in Canadian theatre may shape up to be one of veterans versus newcomers.

Michel Marc Bouchard, whose play Christina, the Girl King is currently on stage at the Stratford Festival, is the most accomplished playwright on the list. His career dates back to the 1980s and his work includes Tom at the Farm, turned into a movie by Xavier Dolan, and Lilies, which was adapted into a film by John Greyson.

Colleen Murphy, who like Bouchard has been writing since the 1980s, is the other veteran playwright on the list. Her recent plays include Pig Girl, a controversial work inspired by the Robert Pickton murders, which premiered in Edmonton last year, and The December Man, a widely-produced play inspired by the Montreal massacre.

Story continues below advertisement

From the younger generation, Hannah Moscovitch has become one of English-Canada's most-produced playwrights only in the past decade. She is best known for her hit East of Berlin, a morally complex play about the son of a Nazi, and This is War, which is set during Canada's mission to Afghanistan.

Finally, Olivier Choinière is the most formally experimental of the contenders. His play Bliss was performed at the Royal Court in London, translated into English by Caryl Churchill, but his other works have veered into the post-dramatic realm and have included audio tours and audacious theatre hacks.

The Siminovitch Prize is given out to a playwright, a director or a designer on a three-year cycle. This year's jury for the playwright award was chaired by John Van Burek. The 2014 prize will be awarded on October 20 at Hart House Theatre in Toronto in an evening hosted by playwright Susan Coyne and comedian Mark McKinney.

Report an error Editorial code of conduct
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter